K221225: Access TSH (3rd IS) Assay, DxI 9000 Access Immunoassay Analyzer (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K221225 (Access TSH (3rd IS) Assay, DxI 9000 Access Immunoassay Analyzer, cleared 2022-11-10 for Beckman Coulter, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K221225
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK221225
Cleared Device Trade / Generic NameAccess TSH (3rd IS) Assay, DxI 9000 Access Immunoassay Analyzer
FDA Applicant on FilingBeckman Coulter, Inc.
FDA 3-Letter Product ClassificationProduct Code JLW
FDA Substantial Equivalence Decision Date2022-11-10
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Danaher Diagnostics across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Beckman Coulter, Inc., compare peer devices under FDA Product Code JLW, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.